Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03203473 |
| Title | Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study) |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Dana-Farber Cancer Institute |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California, San Diego Moores Cancer Center | La Jolla | California | 92093 | United States | Details | |
| University of Chicago Medical Center | Chicago | Illinois | 60637 | United States | Details | |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02115 | United States | Details | |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02115 | United States | Details | |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | United States | Details | |
| Lifespan Comprehensve Cancer Center | Providence | Rhode Island | 02903 | United States | Details | |
| University of Utah, Huntsman Cancer Center | Salt Lake City | Utah | 84112 | United States | Details | |
| Unviersity of Wisconsin Carbone Cancer Center | Madison | Wisconsin | 53792 | United States | Details |